Abstract:Objective: This review describes the discovery during the last five years of novel compounds with significant antimicrobial activity from marine actinomycetes; descriptions include their origins, relevant structures and antimicrobial activities. These antimicrobial compounds belong to several structural classes including alkaloids, peptides, polyketides, macrolides, glycosides, phenols and others. They further express antimicrobial activity against Gram-positive, Gram-negative and fungal pathogens. Method: We additionally summarize the present knowledge of marine actinomycetes, as a potential source for producing antibiotics. Significantly, more than 15 kinds of structures, such as xinghaiamine A (12), and arenimycin (82), showed antimicrobial activity against multidrug resistant (MDR) pathogenic strains. Compounds such as mollemycin A (17, IC50 values of 10 - 50 nM ) and glycosylated macrolactins (83 and 84, MIC values of 0.055 - 0.220 μM) showed potent activity and may be considered as candidates with significant potential for antibiotic drug discovery. Three different types of compounds, lajollamycins (8-11), bahamaolides (95 and 96) and glycosylated benzoxazine (102 and 103) showed inhibitory activity against Candida albicans isocitrate lyase (ICL). Conclusion: As compiled in this review, antimicrobial natural products are frequently found in marine actinomycetes and are an important supply of molecules with great potential for biotechnological applications. Marine actinomycetes, therefore, attracted recent research interest. The opportunities and challenges for exploring marine actinomycetes-derived natural products need to be further elucidated. Keywords: Natural products, antimicrobial activity, marine actinomycetes, structures, antibiotic, pathogen.

Structures, Biosynthesis, and Bioactivity of Oligomycins from the Marine-Derived Streptomyces sp. FXY-T5

Cytotoxic Metabolites from the Marine-Associated Streptomyces Sp. ZZ1944

Derivatives of Holomycin and Cyclopropaneacetic Acid from Streptomyces Sp Dt-A37

Bioactive Metabolites from Marine-Derived Streptomyces Sp A68 and Its Rifampicin Resistant Mutant Strain R-M1

New Metabolites and Bioactive Actinomycins from Marine-Derived Streptomyces sp. ZZ338

OSMAC-Based Discovery and Biosynthetic Gene Clusters Analysis of Secondary Metabolites from Marine-Derived Streptomyces globisporus SCSIO LCY30

Medermycin-Type Naphthoquinones from the Marine-Derived Streptomyces Sp XMA39

Cytotoxic and Antifungal Staurosporine Derivatives from Marine-Derived Actinomycete Streptomyces Sp. ZS-A121

Three New Isoflavonoid Glycosides From The Mangrove-Derived Actinomycete Micromonospora Aurantiaca 110b

Antiproliferative Cyclodepsipeptides from the Marine Actinomycete Streptomyces Sp. P11-23B Downregulating the Tumor Metabolic Enzymes of Glycolysis, Glutaminolysis, and Lipogenesis.

Antiglioma Natural Products from the Marine-Associated Fungus Penicillium Sp. ZZ1750

Bioactive Polycyclic Quinones from Marine Streptomyces Sp. 182SMLY.

Secondary Metabolites from the Mangrove Soil Derived Fungus Xylariaceae Sp. SCSIO41212

Novel Antimycin Analogues with Agricultural Antifungal Activities from the Sponge-Associated Actinomycete <i>Streptomyces </i>sp. NBU3104

Advances in Antimicrobial Natural Products Derived from Marine Actinomycetes

Antiproliferative metabolites against glioma cells from the marine-associated actinomycete Streptomyces sp. ZZ735

Bioactive Secondary Metabolites from Marine Streptomyces griseorubens f8: Isolation, Identification and Biological Activity Assay

Structures and Biosynthetic Pathway of Pulvomycins B-D: 22-Membered Macrolides from an Estuarine Streptomyces sp.

Antimicrobial spiroketal macrolides and dichloro-diketopiperazine from Micromonospora sp. FIMYZ51

Oxazolomycins produced by Streptomyces glaucus and their cytotoxic activity

Alligamycin A, an unprecedented antifungal β-lactone spiroketal macrolide from Streptomyces iranensis